| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| RARG |
RWPE1 (prostate epithelial cells) |
Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP |
Permissive
|
Homo sapiens |
GSE117179
...
|
MA0859.1
...
|
| RARG |
RWPE1 (prostate epithelial cells) |
Treatment: 10 uM DMSO for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP |
Permissive
Robust
|
Homo sapiens |
GSE117179
...
|
MA0859.1
...
|
| RARG |
RWPE1 (prostate epithelial cells) |
Treatment: 10 uM CD437 for 2 hr Gender: male Source: non-malignant prostate cell line infected with BAC-RARG-EGFP |
Permissive
Robust
|
Homo sapiens |
GSE117179
...
|
MA0859.1
...
|
| RBPJ |
CUTLL1 (T-cell lymphoblastic lymphoma 1) |
GSI 72 hrs |
Permissive
|
Homo sapiens |
GSE51800
...
|
MA1116.1
|
| RBPJ |
CUTLL1 (T-cell lymphoblastic lymphoma 1) |
GSI 72 hrs, wash out 4 hrs |
Permissive
Robust
|
Homo sapiens |
GSE51800
...
|
MA1116.1
|
| RBPJ |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 0 Passage: P3-6 |
Permissive
|
Homo sapiens |
GSE109625
...
|
MA1116.1
|
| RBPJ |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 1 Passage: P3-6 |
Permissive
|
Homo sapiens |
GSE109625
...
|
MA1116.1
|
| RBPJ |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 4 Passage: P3-6 |
Permissive
|
Homo sapiens |
GSE109625
...
|
MA1116.1
|
| RBPJ |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 12 Passage: P3-6 |
Permissive
|
Homo sapiens |
GSE109625
...
|
MA1116.1
|
| RBPJ |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: Superconfluent, untreated Passage: 4 |
Permissive
|
Homo sapiens |
GSE87552
...
|
MA1116.1
|
Showing 10 records in page 695
from 963 pages